Matthias Briel

1998–2025 年に発表

119
論文数
24,055
被引用数
75
h 指数
116
i10 指数

被引用数

Matthias Briel の年別被引用数1991 年: 被引用 1 件1999 年: 被引用 5 件2000 年: 被引用 3 件2001 年: 被引用 1 件2002 年: 被引用 2 件2003 年: 被引用 3 件2004 年: 被引用 5 件2005 年: 被引用 6 件2006 年: 被引用 28 件2007 年: 被引用 87 件2008 年: 被引用 74 件2009 年: 被引用 83 件2010 年: 被引用 102 件2011 年: 被引用 120 件2012 年: 被引用 141 件2013 年: 被引用 223 件2014 年: 被引用 198 件2015 年: 被引用 242 件2016 年: 被引用 279 件2017 年: 被引用 320 件2018 年: 被引用 264 件2019 年: 被引用 733 件2020 年: 被引用 878 件2021 年: 被引用 717 件2022 年: 被引用 539 件2023 年: 被引用 460 件2024 年: 被引用 754 件2025 年: 被引用 393 件2026 年: 被引用 17 件1992〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,301 件、この内訳の 17.6%イギリス: 引用元論文 1,149 件、この内訳の 8.8%カナダ: 引用元論文 1,037 件、この内訳の 8%イタリア: 引用元論文 710 件、この内訳の 5.4%ドイツ: 引用元論文 693 件、この内訳の 5.3%中国: 引用元論文 587 件、この内訳の 4.5%オーストラリア: 引用元論文 562 件、この内訳の 4.3%フランス: 引用元論文 523 件、この内訳の 4%オランダ: 引用元論文 506 件、この内訳の 3.9%スイス: 引用元論文 498 件、この内訳の 3.8%スペイン: 引用元論文 432 件、この内訳の 3.3%ブラジル: 引用元論文 282 件、この内訳の 2.2%
0%17.6%その他 28.9%

分野

  • Medicine79.1%
  • Decision Sciences3.5%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Health Professions2.4%
  • Nursing1.9%
  • Immunology and Microbiology1.7%
  • その他8.2%

トピック

  • Respiratory Support and Mechanisms5.8%
  • Sepsis Diagnosis and Treatment3.5%
  • Diet and metabolism studies2.3%
  • Nosocomial Infections in ICU2.2%
  • Meta-analysis and systematic reviews2%
  • Bariatric Surgery and Outcomes1.8%
  • その他82.4%

共著者

全論文

検索で開く
  1. Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses

    著者: , , , , , , , , , , , , , , , - Canadian Medical Association Journal 2020 被引用: 717

  2. Driving Pressure and Survival in the Acute Respiratory Distress Syndrome

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 2,808

  3. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials

    著者: , , , , , , , - BMJ 2013 被引用: 1,338

  4. Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome

    著者: , , , , , , , , , , , , , , , - JAMA 2010 被引用: 1,468

  5. GRADE guidance 36: updates to GRADE's approach to addressing inconsistency

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2023 被引用: 120

  6. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bin Cao, Yahya Shehabi, Jens‐Ulrik Stæhr Jensen, Caspar Corti, Jos A. H. van Oers, Albertus Beishuizen, Armand R. J. Girbes, Evelien de Jong, Matthias Briel, Beat Müeller - The Lancet Infectious Diseases 2017 被引用: 473

  7. Effects of Low-Carbohydrate vs Low-Fat Diets on Weight Loss and Cardiovascular Risk Factors

    著者: , , , , , , - Archives of Internal Medicine 2006 被引用: 976

  8. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses

    著者: , , , - BMJ 2010 被引用: 812

  9. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Schandelmaier, Yazdan Yazdanpanah, Dominique Costagliola, Inge Christoffer Olsen, Matthias Briel - The Lancet Respiratory Medicine 2023 被引用: 124

  10. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yahya Shehabi, Albertus Beishuizen, Jens‐Ulrik Stæhr Jensen, Caspar Corti, Jos AH van Oers, Ann R. Falsey, Evelien de Jong, Carolina Oliveira, Bianca Beghé, Matthias Briel, Beat Müeller - Cochrane Database of Systematic Reviews 2017 被引用: 648

  11. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 406

  12. Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

    著者: , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 621

  13. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta‐analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert D. McBane, Uwe Pelzer, Hanno Riess, Ziad Solh, James Perry, Lara A Kahale, Patrick M. Bossuyt, Clara Klerk, Harry R. Büller, Elie A. Akl, Holger J. Schünemann - Journal of Thrombosis and Haemostasis 2020 被引用: 121

  14. Meta-Analysis Comparing Mediterranean to Low-Fat Diets for Modification of Cardiovascular Risk Factors

    著者: , , , , , , - The American Journal of Medicine 2011 被引用: 295

  15. GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2017 被引用: 130

  16. Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada

    著者: , , , , , - Trials 2021 被引用: 118

  17. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection

    著者: , , , , , - Cochrane Database of Systematic Reviews 2015 被引用: 223

  18. Prevalence, Characteristics, and Publication of Discontinued Randomized Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bradley C. Johnston, Martin A. Walter, Bernard Burnand, Matthias Schwenkglenks, Lars G. Hemkens, Heiner C. Bucher, Gordon Guyatt, Matthias Briel - JAMA 2014 被引用: 430

  19. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review

    著者: , , , , , , , , , , , , , , , , , , , , - BMJ 2012 被引用: 358

  20. Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016

    著者: , , , , , , , , , , , , , , , - JAMA Network Open 2020 被引用: 97

  21. Somatostatin Receptor–Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial

    著者: , , , , , , , - Journal of Nuclear Medicine 2015 被引用: 94

  22. Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysis

    著者: , , , , , , , - Heart Rhythm 2018 被引用: 89

  23. Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia

    著者: , , , , , , , , , , - Annals of Internal Medicine 2015 被引用: 325

  24. Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research

    著者: , , , , , , , , - PLoS ONE 2017 被引用: 233